March 27, 2020
Yoshindo is curbing shipments of its tranexamic acid 250 mg and 500 mg products as the novel coronavirus outbreak has disrupted API supplies from China, with their stable distribution unlikely to resume until July. The Yoshindo products are generic versions...read more